Assignee
AMYGDALA NEUROSCIENCES INC
US·4 granted patents·5 pending applications·3 citations·filing 2017–2024
Top patents by PatentIndex Score
9 records- 0183US9987295B2Compounds for the treatment of addictionAMYGDALA NEUROSCIENCES INC·Filed 2017·Granted Jun 5, 2018·3 cites·18 claims
- 0273US12351569B2ALDH-2 inhibitor compounds and methods of useAMYGDALA NEUROSCIENCES INC·Filed 2023·Granted Jul 8, 2025·0 cites·26 claims
- 0373US12018009B2ALDH-2 inhibitor compounds and methods of useAMYGDALA NEUROSCIENCES INC·Filed 2023·Granted Jun 25, 2024·0 cites·10 claims
- 0465US2025381182A1Aldh-2 inhibitor compounds and methods of useAMYGDALA NEUROSCIENCES INC·Filed 2024·Application pending·0 cites
- 0564US10507215B2Compounds for the treatment of addictionAMYGDALA NEUROSCIENCES INC·Filed 2018·Granted Dec 17, 2019·0 cites·13 claims
- 0661US2023399299A1Aldh-2 inhibitor compounds and methods of useAMYGDALA NEUROSCIENCES INC·Filed 2023·Application pending·0 cites
- 0752US2021145844A1Combination therapy for nicotine addictionAMYGDALA NEUROSCIENCES INC·Filed 2021·Application pending·0 cites
- 0850US2021220376A1Addiction treatment of an alcohol-consuming patient populationAMYGDALA NEUROSCIENCES INC·Filed 2021·Application pending·0 cites
- 0948US2020237789A1Combination therapy for preventing addictionAMYGDALA NEUROSCIENCES INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →